Código QR (código de barras bidimensional)

Onabotulinumtoxin-A: Previous Prophylactic Treatment Might Improve Subsequent Anti-CGRP Monoclonal Antibodies Response in Patients with Chronic Migraine

The aim of the present study was to evaluate whether previous preventive treatment with onabotulinumtoxin-A might influence subsequent clinical response following a switch to anti-CGRP monoclonal antibodies (mAbs). The present retrospective study was conducted at the Headache Centre—Neurology Clinic...

ver descrição completa

Na minha lista:
Principais autores: Giulia Ceccardi, Francesca Schiano di Cola, Salvatore Caratozzolo, Michele Di Pasquale, Marco Bolchini, Alessandro Padovani, Renata Rao
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI AG 2023-11-01
coleção:Toxins
Assuntos:
migraine
chronic migraine
onabotulinumtoxin A
CGRP
anti-CGRP monoclonal antibodies
prevention
Acesso em linha:https://www.mdpi.com/2072-6651/15/12/677
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados